Using reversed-phase "high-performance" liquid chromatography and hydrophilic ion-pairing reagents, we studied the chromatographic profiles of corticotropin immunoreactivities in human plasma, cerebrospinal fluid, and urine. The chromatographic system we applied provides excellent separation of peptide molecules, with reproducibility (CV) of retention times better than 0.5%, and makes feasible the subsequent immunological quantitation of eluted fractions. Profiles of coriicotropin immunoreactivities exhibited several chemically different compounds in each of the three body fluids studied. A considerable portion of these immunoreactive compounds is more hydrophilic and probably of lower molecular mass than the human corticotropin 1-39 molecule itself. These hydrophilic molecules are more predominant in urine and plasma than in cerebrospinal fluid.
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Using reversed-phase "high-performance" liquid chromatography and hydrophilic ion-pairing reagents, we studied the chromatographic profiles of corticotropin immunoreactivities in human plasma, cerebrospinal fluid, and urine. The chromatographic system we applied provides excellent separation of peptide molecules, with reproducibility (CV) of retention times better than 0.5%, and makes feasible the subsequent immunological quantitation of eluted fractions. Profiles of coriicotropin immunoreactivities exhibited several chemically different compounds in each of the three body fluids studied. A considerable portion of these immunoreactive compounds is more hydrophilic and probably of lower molecular mass than the human corticotropin 1-39 molecule itself. These hydrophilic molecules are more predominant in urine and plasma than in cerebrospinal fluid. Ten-milliliter samples of whole blood from normal subjects were withdrawn into cooled tubes containing200 1zL of a 50 g/L EDTA solution, 5000 kilo-mt.units of aprotinin (Trasylol; Bayer Ltd.,Leverkusen, F.R.G.), and 20 1zL of mercaptoethanol, and promptly centrifuged (15 mm, 2000 X g, 4 #{176}C). The plasma was stored frozen until required for analysis.
The CSF was from patients who had undergone a spinal tap because of suspected meningitis, with negative results. The CSF samples were frozen after the lumbar tap. The urine samples for analysis were freshly collected.
Extraction.
We extracted the samples by a solid-phase technique similar to that originally outlined by Bennett et al. (Figure 1 ) emphasize that the resolving power of the chromatographic system is sustained even though there is a considerably higher mass to be chromatographed (about 2 mg for the plasma extract).
Profiles of "ACTH-like" immunoreactive compounds. Figure 3 shows representative profiles of ACTH-immunoreactive compounds in human plasma, CSF, and urine. Similarities were apparent between the profiles for plasma and urine, with significant amounts of immunoreactive compounds in the more hydrophilic part of the chromatogram (short retention times) and almost equivalent or slightly higher amounts in the more hydrophobic part (longer retention times). In CSF, the immunoreactivities mostly were eluted in the more hydrophobic part of the chromatogram. When one considers all these profiles, it becomes evident that "ACTH-like" immunoreactive compounds are assayable in all body fluids studied and that immunoreactivities are not Results attributable to one peptide molecule, but rather to several that differ significantly in hydrophobicity. Most of the immunoreactive compounds elute at other retention times than that of the synthetic human ACTHI_39 molecule.
Discussion
The reversed-phase version of the HPLC technique involving the use of ion-pairing reagents in the mobile phase provides excellent separatiQn of peptide molecules (5, 6), but the high salt concentrations used in most of these studies render these systems unsuitable for subsequent immunological quantitation of the eluates. The present system, which is described in more detail elsewhere (11) , not only efficiently separates these peptide molecules, but makes it feasible to immunoassay the chromatographic eluates.
Studies on the nature of the ACTH-immunoreactive compounds in human body fluids are almost exclusively restricted to immunoreactive profilesevaluated by the gel-filtration technique (2-4) . Consequently, the ACTH1_39 molecule itself and the forms of larger molecular mass in patients with the ectopic ACTH syndrome have been separated (2, 3) . In plasma of normal subjects, only one immunoreactive compound is reported that elutes with the same retention time as that of synthetic human ACTHI_39 (4 compounds. Nevertheless, there already is substantial evidence that specific assessment of the "true" ACTH concentration represents a considerable analytical challenge. Until the biological significance of the different immunoreactive molecules is elucidated, it is advisable, in laboratory diagnosis, to keep in mind that estimates of total ACTH immunoreactivity in body fluids, especially inplasma, may not necessarily accurately reflect pituitary ACTH secretion and that, potentially, other mechanisms than pituitary secretion or other sources than the pituitary itself may account for some of the ACTH-immunoreactivity measured.
